Thomas Frank spoke to the media at Hotspur Way on Friday afternoon, ahead of Saturday's Premier League clash against Brighton at the Amex (3pm UK). Here's what he had to say... Q1: What's the latest ...

Texas Attorney General Ken Paxton said he wants all schools in Texas to make time for Bible reading and prayer. "As I've always said and believed, we want the word of God opened, the Ten Commandments ...

Anthropic's Claude can now create PDFs, slides, and spreadsheets. File creation is available to Max, Team, and Enterprise users. Pro users will get access in the upcoming weeks. AI chatbots such as ...

Black Ops 6 Season 5 offered a boatload of content at launch, from new weapons like the ABR A1 to the arrival of 6v6 maps like W.M.D. and Exchange. However, the Reckoning may be the biggest addition ...

In locations that do not currently experience vector-borne disease (VBD) outbreaks but may be at risk under climate change, modeling future climate suitability for transmission is important for ...

National Public Data was the target of a massive hack in early 2024, which led to billions of records being leaked. The site has since returned under new ownership. The site now allows you to search ...

The newly declassified annex to special counsel John Durham‘s 2023 report reveals that the Obama-era FBI failed to investigate credible intelligence indicating the Hillary Clinton campaign was ...

Create a professional email identity by setting up your custom email domain. This guide walks you through every step to get your personalized email address up and running. Creating your own email ...

Development of the Patient-Reported Indicator Surveys (PaRIS) conceptual framework to monitor and improve the performance of primary care for people living with chronic conditions (22 August, 2024) ...

Finding the best ebook formatting services can feel like searching for a needle in a haystack. Your manuscript looks perfect in Word, but it turns into a formatting disaster on Kindle devices. Many ...

Correction: Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU (7 July, 2025) ...